AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Paige vs Tempus AI

VS
Paige official logo and brand icon

Paige

Enterprise
Visit WebsiteFull Review
Tempus AI official logo and brand icon

Tempus AI

Enterprise
Visit WebsiteFull Review

Verdict by Category

Detailed category analysis is not available for this comparison.
View Paige View Tempus AI
Feature & Spec Matrix

Detailed Comparison24 Criteria

Complete side-by-side breakdown of specifications, capabilities, and feature parity

Swipe horizontally to compare features
Feature / Spec
Paige
Paige
Tempus AI
Tempus AI
Pricing Model
EnterpriseAI clinical pathology diagnostics — Institutional and hospital laboratory enterprise licensing
EnterpriseGenomic sequencing, clinical data analytics, and precision medicine AI — Custom institutional agreements for healthcare systems and life sciences
Starting Price
Custom / Contact Sales
Custom / Contact Sales
Free Plan & Trial Scope
Difference
No free plan — enterprise hospital and biopharma contracts via sales team
No free plan — genomic tests ordered by physicians; enterprise and biopharma data partnerships via sales
User Rating Score
Unrated
Unrated
Ideal Workflow / Use Case
Difference
Cancer centers, hospital pathology labs, and biopharma companies needing FDA-cleared AI for prostate and breast cancer diagnosis, digital pathology viewing, and biomarker research
Oncologists, health systems, and biopharma companies needing AI-powered genomic profiling, precision medicine insights, clinical trial matching, and drug development data
Enterprise & Scalability
Difference
FDA 510k cleared primary diagnosis AI, CE marked, HIPAA compliant, SOC 2 Type II, CAP/CLIA compatible lab workflows, HL7/FHIR integration, GPU infrastructure with 10+ petaFLOPS AIRI compute, enterprise pathology scanner compatibility (Leica Aperio, Hamamatsu NanoZoomer, Philips IntelliSite), and dedicated implementation support
CLIA-certified genomics laboratory, CAP accredited, HIPAA compliant, SOC 2 Type II, de-identified patient data network of 7M+ records, EHR integration via HL7/FHIR, biopharma licensing agreements, and enterprise analytics platform with dedicated clinical account management
Core Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education Tools
FullFocus — FDA 510k-cleared digital pathology image viewer compatible with Leica, Hamamatsu, and Philips scanners
Difference
Paige Advantage
Not listed
Paige Prostate — FDA-cleared AI for prostate cancer detection and Gleason grading
Difference
Paige Advantage
Not listed
Paige Breast — AI-assisted breast cancer detection and analysis on whole slide images
Supported
Supported
First ever FDA clearance for AI in primary pathology diagnosis — historic regulatory milestone
Difference
Paige Advantage
Not listed
First CE mark in AI pathology — cleared for clinical use across EU member states
Supported
Supported
AIRI infrastructure with 10+ petaFLOPS GPU compute for large-scale model training
Difference
Paige Advantage
Not listed
1.2M+ slide digital archive from Memorial Sloan Kettering for model training
Difference
Paige Advantage
Not listed
Biopharma platform for biomarker discovery, companion diagnostics, and drug development
Supported
Supported
Scanner-neutral slide viewer compatible with multiple FDA-cleared scanner systems
Difference
Paige Advantage
Not listed
Spinout from Memorial Sloan Kettering with exclusive access to MSK's pathology IP and 25M+ slides
Difference
Paige Advantage
Not listed
Comprehensive genomic profiling — solid tumor (xT), germline (xG), RNA (xR), liquid biopsy (xF), and expression (xE) testing
Difference
Not listed
Tempus AI Advantage
AI-powered clinical trial matching (TIME Trial) to improve enrollment rates and identify eligible patients
Difference
Not listed
Tempus AI Advantage
Tempus One — AI clinical assistant for real-time treatment insights and literature synthesis at point of care
Difference
Not listed
Tempus AI Advantage
Neuropsychiatry panel for pharmacogenomics and psychiatric medication response prediction
Difference
Not listed
Tempus AI Advantage
Algos platform for population health analytics across health system patient cohorts
Difference
Not listed
Tempus AI Advantage
CLIA-certified lab with CAP accreditation for clinical-grade genomic report delivery
Difference
Not listed
Tempus AI Advantage
Publicly traded (NASDAQ: TEM) — founded 2015, 3,800+ employees, $8.79B total raised
Difference
Not listed
Tempus AI Advantage
Paige icon

Paige Pros & Cons

Pros

  • First FDA clearance for AI in primary pathology diagnosis — a historic regulatory milestone
  • First CE mark for AI pathology in Europe — validated for clinical use across EU
  • Founded on MSK's 25M+ pathology slides — the richest cancer pathology training set in the world
  • AIRI infrastructure with 10+ petaFLOPS — enterprise-grade AI compute at clinical scale
  • FullFocus viewer is scanner-neutral with FDA clearances for Leica, Hamamatsu, and Philips
  • The most credentialed AI pathology company in terms of regulatory approvals
  • Backed by Goldman Sachs, Breyer Capital, and Healthcare Venture Partners

Cons

  • Enterprise and institutional access only — not available to small or independent pathology labs
  • No published pricing — all contracts negotiated through enterprise procurement
  • Requires digital pathology infrastructure — scanners, storage, and LIS integration
  • Pathologist review and sign-off still required for all AI-generated results
  • Focused on pathology and oncology — not a general medical imaging platform
Tempus AI icon

Tempus AI Pros & Cons

Pros

  • Publicly traded (NASDAQ: TEM) — one of the most credible precision medicine AI companies
  • 7M+ de-identified patient records — one of the world's largest clinical-molecular datasets
  • Comprehensive genomic testing across 6 test types covering all major oncology applications
  • Tempus One AI provides real-time clinical insights at the point of care
  • TIME Trial dramatically improves clinical trial matching and enrollment rates
  • 3,800+ employees and $8.79B total capital raised since founding
  • Expanding beyond oncology into neuropsychiatry, cardiology, and infectious disease

Cons

  • Enterprise and institutional pricing — not accessible to individual clinicians or small practices
  • Focused primarily on oncology and genomics — not a general-purpose clinical AI tool
  • Genomic test turnaround requires laboratory processing time
  • Data platform access and licensing requires formal agreements
  • Some AI insights require institutional genomic data infrastructure to fully leverage
Head-to-Head Battle Cards

Popular Comparisons

Direct feature matrices, pricing breakdowns, and real-world benchmark duels

All AI Healthcare Tools comparisons
Tempus AI vs Insilico Medicine Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Insilico Medicine in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Tempus AI vs Atomwise Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Atomwise in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Tempus AI vs Nabla Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Tempus AI and Nabla in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare
Paige vs Suki AI Comparison Battle Card - Features, Pricing & Review in AI Healthcare Tools
Direct head-to-head AI tool comparison between Paige and Suki AI in AI Healthcare Tools featuring side-by-side feature matrix, pricing tiers, and benchmark verdict.
AI Healthcare ToolsCompare